Search

Colorado Adopts Controls on Five Toxic Air Pollutants from Key Industries

The Colorado Air Quality Control Commission adopted emission control measures for five priority air toxic contaminants — benzene, ethylene oxide, formaldehyde, hexavalent chromium compounds, and hydrogen sulfide — under the Public Protections From Toxic Air Contaminants Act (HB22-1244). Affected facilities must reduce emissions through new technologies, adjusted work practices, and less toxic materials. New sources face more stringent requirements than existing sources, and the regulations prioritize reductions near disproportionately impacted communities.

Explanatory Note: Interim Order Respecting Prevention and Alleviation of Drug Shortages in Relation to COVID-19

Health Canada has issued an Interim Order (effective October 16, 2020) granting the Minister of Health new powers to address drug shortages caused or exacerbated by COVID-19. The order authorizes the Minister to compel any person selling a drug to provide information about shortages or potential shortages, and to impose or amend terms and conditions on drug sale authorizations. The order ceases to have effect 14 days after being made unless approved by the Governor in Council.

Interim Order Expedites COVID-19 Drug Importation and Sale

Health Canada signed the Interim Order Respecting the Importation, Sale and Advertising of Drugs for Use in Relation to COVID-19 on September 16, 2020. The Order establishes expedited authorization pathways allowing the Minister to consider urgent public health needs when evaluating drugs for COVID-19, including evidence from foreign regulatory approvals. It also enables more agile establishment licensing and permits the Public Health Agency of Canada to pre-position promising drugs before full authorization. The Order was made under subsection 30.1(1) of the Food and Drugs Act and requires an Order in Council to remain in effect beyond 14 days.

Biodegradable Lung Sealant PEG Hydrogel Patent Granted to Ethicon

USPTO granted patent US12599624B2 to Ethicon, Inc. for a rapid-setting biodegradable lung sealant comprising two multi-arm polyethylene glycol (PEG) compositions. The first PEG composition contains an alkaline buffer and the second contains a mildly acidic buffer, providing optimized setup time and extended working time. The formulation may include tocopherol as a radioprotectant and a colorant for improved visualization against lung tissue. The patent contains 22 claims and is classified under CPC codes A61K and A61P.

Drug Delivery System and Methods of Using the Same

The USPTO granted Axogen Corporation Patent US12599701B2 for a drug delivery system combining polydioxanone polymer with neuro-regenerative or immunosuppressive agents to form an implantable biomaterial. The patent includes 16 claims covering the method of combining, melting, and extruding the polymer with at least one immunophilin ligand. The invention is classified under CPC codes including A61P 25/02 (nervous system therapeutic activity) and A61L 27/54.

Dana McLaughlin LPC Restrictions Terminated, New Jersey

The New Jersey Professional Counselor Examiners Committee has issued an order terminating all license restrictions imposed on Dana McLaughlin, LPC (License No. 37PC00581700). The restrictions, originally imposed in December 2022 following a complaint, included a stayed suspension, supervised practice requirements, and a prohibition on supervising others. The Committee determined that McLaughlin satisfied all conditions of the Consent Order, including completing required coursework and receiving supervisor attestation of readiness for independent practice. McLaughlin may now practice professional counseling in New Jersey without restriction.

Oregon Board of Dentistry Amends Nine Rules, Updates Fees

The Oregon Board of Dentistry filed amendments to nine administrative rules (OBD 2-2025), effective December 1, 2025. The filing includes updated biennial license fees for dental, dental hygiene, and dental therapy professions, along with new patient care standards requiring written informed consent for botulinum toxin and dermal filler administration. Additional changes address medication storage requirements and expand dental hygienist scope of practice to include extraoral procedures.

Shiseido Granted Patent for Skin Composition Formulations and Methods

USPTO granted Patent US12599623B2 to Shiseido Company, Limited on April 14, 2026. The patent covers body corrective cosmetic formulations and methods of use thereof, including skin treatment compositions. The application was filed on June 29, 2017 under Application No. 15638059 with 13 claims.

METHOD AND SYSTEM FOR MODELING PREDICTIVE OUTCOMES OF ARTHROPLASTY SURGICAL PROCEDURES

The European Patent Office published patent application EP4135620A1 for Exactech, Inc., covering a method and system for modeling predictive outcomes of arthroplasty surgical procedures. The A1 publication includes the search report and is now publicly available across all designated EU member states. The patent protects predictive modeling technology for orthopedic joint replacement planning.

Selective Targeting of Host CD70+ Alloreactive Cells to Prolong Allogeneic CAR T Cell Persistence

The European Patent Office published patent application EP4355358A1 on April 8, 2026, filed by Allogene Therapeutics, Inc. The invention covers methods for selectively targeting host CD70+ alloreactive cells to enhance persistence of allogeneic CAR-T cells for therapeutic use. The patent is designated across multiple European member states including Germany, France, and the United Kingdom.

RNA-Based Control of Powdery Mildew - Greenlight Biosciences EP4304353A2

EPO published patent application EP4304353A2 by Greenlight Biosciences Inc. for RNA-based control of powdery mildew, a fungal disease affecting plants. The application covers double-stranded RNA compositions and methods for controlling fungal pathogens in agriculture. The patent designation extends across 38 European member states including Germany, France, and the United Kingdom.

EP4347847A1 - Flexible Expression Vector Systems for Vaccines and Immunotherapeutics

The European Patent Office granted patent EP4347847A1 to The University of British Columbia and The James Hutton Institute. The patent covers flexible expression vector systems and their applications in vaccines and immunotherapeutics, with inventors Jefferies and Ribeca. The patent is designated across 31 European member states.

Lipid Nanoparticle Stem Cell Therapeutics - European Patent EP4330391A1

The European Patent Office granted Patent EP4330391A1 to the Trustees of the University of Pennsylvania for compositions and methods targeting lipid nanoparticle therapeutics to stem cells. The patent covers IPC classifications including A61K 47/69, A61K 47/68, A61K 9/51, C12N 15/88, and A61K 48/00. The patent is valid in 35 designated European member states including Germany, France, the United Kingdom, Italy, and Spain.

Tumor Infiltrating Lymphocytes Therapy

The European Patent Office published patent application EP4329782A1 for Alethia Biotherapeutics ULC covering tumor infiltrating lymphocytes (TIL) therapy for cancer treatment. The application includes 17 IPC classifications including cell compositions, antibodies, and combination therapies. The patent designates 35 European states including Germany, France, UK, Italy, Spain, and the Netherlands.

Psychological Analysis Method Based on Image Generation Process

The European Patent Office published European Patent application EP2024071678A1 for a psychological analysis method based on an image generation process. The patent grants intellectual property rights to Bax Intelligence Inc for the designated states across 38 European countries. The IPC classifications indicate applications in medical measurement (A61B 5/16, A61B 5/00), health informatics (G16H 10/20), and therapeutic interventions (G16H 20/70).

Rehabilitation Exercise Recommendation via Digital Image Recognition

The European Patent Office published patent application EP2024053989A1 for His Cares Inc., covering a system and method for recommending rehabilitation exercises using digital image recognition to detect a patient's living environment. The patent classifies under G16H (Health Informatics) and A61B (Measuring/Diagnosing). The designation covers 31 European states including Germany, France, the UK, Italy, and Spain.

Pulmonary Disease Therapy Planning Methods and Systems - Apreo Health

The European Patent Office granted patent EP4643348A1 to Apreo Health, Inc. on April 8, 2026. The patent covers methods and systems for planning, predicting, and monitoring therapies for pulmonary diseases, incorporating health informatics (G16H), medical imaging (A61B), AI/ML (G06N), and therapy monitoring technologies. The patent is designated for all EU member states and EPO contracting states.

BOE Intelligent Triage Patents Patient-Doctor Matching System

USPTO granted patent US12603169B2 to BOE TECHNOLOGY GROUP CO., LTD. on April 14, 2026. The patent covers an intelligent triage method using disease information vectorization and a matching degree calculation model to recommend doctors to outpatients. The system analyzes patient disease vectors against doctor vectors extracted from a doctor knowledge graph to calculate matching degrees for patient-doctor recommendations.

US12603160B2: Mobile Cloud App QR Immune Score

USPTO granted Patent US12603160B2 to Andrew Brooks for a system and method enabling mobile cloud-based assessment of immune status related to transmissible infectious diseases. The system uses QR code scanning to access user health records including immunization data, test results, and pre-existing conditions, displaying verified immunity scores on venue devices. The patent covers 15 claims under CPC classifications G16H 10/60, G16H 40/67, and G06K 19/06037.

VIAVI Solutions Medication Verification System Using Spectrometry

USPTO granted patent US12603167B2 to VIAVI Solutions Inc. on April 14, 2026. The patent covers a medication assurance system that uses a portable spectrometer to obtain light spectra of medications and performs chemometric analysis to identify medications. The system also incorporates biometric patient identification to verify medication appropriateness for individual patients.

Automated Medical AI Training Data Generation Patent US12603176B2

USPTO granted patent US12603176B2 to SMART REPORTING GMBH covering a computer-implemented method, system, and computer program product for automatically generating medical training data to train AI algorithms supporting clinical reporting and documentation. The invention receives medical image data, generates or edits findings reports with machine-readable elements, automatically assigns semantic content to unique identifiers, and annotates image data by linking image elements to findings report identifiers for storage as AI training data.

Piperidinyl Aryloxy Propanamides and Propanoates Patent EP3759094A1

The European Patent Office published patent application EP3759094A1 for Takeda Pharmaceutical Company Limited covering piperidinyl-3-(aryloxy)propanamides and propanoates compounds. The patent application includes therapeutic indications for depression (A61P 25/24), CNS disorders (A61P 25/28), and psychiatric disorders (A61P 25/18). The application designates multiple European states including Germany, France, United Kingdom, Italy, Spain, and others.

Novel Pyrazole Compounds for Inflammatory Disease Treatment

The European Patent Office has published patent EP3759103A1, granting Inflazome Limited intellectual property protection for novel pyrazole-derived compounds. Inventors include David Miller, Jimmy Van Wiltenburg, and Matthew Cooper. The compounds are classified under A61K 31/415 with therapeutic applications targeting inflammatory diseases.

Solid Form Composition for Use in Treatment of Extraoesophageal Symptoms of Gastric Reflux

The European Patent Office published patent application EP3752202A1 filed by Drugs Minerals and Generics Italia S.R.L. for a solid dosage form composition intended for treating extraoesophageal symptoms of gastric reflux. The application, filed with inventor Luigi Mercuri, designates multiple EU member states including DE, FR, GB, IT, ES, NL, and 24 others. This publication establishes a priority date for the claimed pharmaceutical composition.

Base-Modified Cytidine Nucleotides for Leukemia Therapy (EP3810140A1)

The European Patent Office published patent application EP3810140A1 for Medivir Aktiebolag covering base-modified cytidine nucleotides for leukemia therapy. The application includes IPC classifications for A61K 31/506 (pyrimidine derivatives), C07D 405/04 (heterocyclic compounds), and A61P 35/02 (antineoplastic agents). The patent designates all EPO member states including AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR.

Pfizer CD70 CAR Chimeric Antigen Receptor Patent Application EP3746483A1

The European Patent Office published Pfizer Inc.'s patent application EP3746483A1 for chimeric antigen receptors targeting CD70. The application (A1 publication with European search report) covers compositions and methods for CD70-targeting CARs with 11 named inventors including Srivatsa Srinivasan and Barbra Johnson Sasu. The application designates all EU member states plus other EPC contracting states.

COVID-19 Continuing Education Requirements Extension for Naturopathic Physicians

The Washington State Board of Naturopathy adopted policy BON 20-01.1 extending continuing education (CE) requirements for naturopathic physicians during COVID-19. The board exercised authority under WAC 246-12-210 to grant CE extensions due to extenuating circumstances. Naturopathic physicians who attested to CE through September 30, 2020 received coinciding extensions with their license renewals. The board will accept online and prerecorded courses meeting WAC 246-836-080 requirements through December 31, 2021. Case-by-case consideration applies to other circumstances beyond licensees' control.

License Holders Must Disclose Sexual Misconduct to Patients

Washington State's RCW 18.130.063 requires license holders who have been sanctioned for sexual misconduct on or after October 1, 2019, to disclose this to patients before or at their first appointment. Licensees must provide the public order or stipulation, describe all sanctions and their duration, include the disciplining authority's phone number, and explain how to access more information on the license lookup website. Patients or their surrogate decision makers must sign an acknowledgment of receipt, which must be kept in the patient's file.

Surgical Stapler with Removable Power Pack, EP3998960A1

European Patent Office published patent EP3998960A1 granting Revmedica, Inc. exclusive rights to a surgical stapler with removable power pack. The patent application was filed by inventors SATTI, WENCHELL, and NIELSEN with IPC classifications covering surgical stapling devices (A61B 17/072, A61B 17/068, A61B 17/115). The patent covers designated European Patent Convention states including DE, FR, GB, IT, ES, NL, and 22 other member states.

Surgical Robotic Arm with Anatomy State Confirmation, Covidien

The European Patent Office published patent EP4072460A1 for Covidien LP covering a surgical robotic arm system with anatomy state confirmation technology. The invention is classified under IPC A61B (Diagnosis and Surgery) and includes robotic arm mechanisms for confirming anatomical states during surgical procedures. The patent names Meglan Dwight as inventor.

Vascular Access Device with Arteriovenous Fistula Support EP4037754A1

The European Patent Office published patent application EP4037754A1 for a vascular access device designed to support arteriovenous fistulas. The patent was filed by Voyager Biomedical, Inc. and inventors Alan Glowczwski and Kimberly Marie Neely. The invention is classified under A61B 17/11 (surgical anastomosis) and A61M 39/02 (vascular implants).

EP4044910A1 Monitoring of Breathing and Heart Function Patent

The European Patent Office published patent application EP4044910A1 titled 'Monitoring of Breathing and Heart Function' filed by The Children's Medical Center Corporation. Inventors Benjamin Matthews and Christopher Norve developed a system for monitoring breathing and heart function with applications in medical diagnostics. The patent application was published with designated state coverage across European Patent Convention member states including Germany, France, United Kingdom, Italy, Spain, and 23 other countries.

Intra-Oral Electroencephalography Device and Method for Neurological Diagnosis

The European Patent Office granted Patent EP4054420A1 to Achaemenid, LLC for an intra-oral electroencephalography (EEG) device designed for neurological diagnosis. The invention (Inventor: Reza Radmand) utilizes IPC classifications including A61B 5/291 (electrical recording of physiological state), A61B 5/384 (brain monitoring), and A61B 5/11 (movement measurement). The patent is designated for all 35 participating EPC contracting states including Germany, France, the United Kingdom, Italy, Spain, and other EU member states.

Systems and Methods for Automated Ultrasound Image Labeling and Quality Grading

The European Patent Office published patent application EP4028992A1 for Echonous, Inc., titled 'Systems and Methods for Automated Ultrasound Image Labeling and Quality Grading.' The invention covers automated systems using neural networks to label ultrasound images and assess image quality. The patent is designated for all 39 EPC contracting states including DE, FR, GB, IT, ES, NL, and others.

Endoscopic System and Method for Operating the Same (EP4027183A1)

The EPO published patent application EP4027183A1 for Fujifilm Corporation's endoscopic system and method for operating the same. The patent relates to an endoscopic device classified under IPC A61B covering diagnosis and surgery applications. The publication provides intellectual property protection for the disclosed invention across all designated EPC contracting states including AL, AT, BE, DE, FR, GB, IT, NL, and 32 others.

Brain Control Interface Patent - Synchron Australia

The European Patent Office published patent application EP4048371A1 for Synchron Australia Pty Ltd, covering systems and methods for configuring a brain control interface using data from deployed systems. The patent application includes claims related to A61N 1/05 (neural electrodes), A61N 1/36 (nerve stimulation), and related classifications. The application designates multiple European member states including DE, FR, GB, IT, NL, and others.

Penn State Research Foundation Multi-Destination Endoscopic Surgery Planning System Patent EP4468937A1

The European Patent Office published patent application EP4468937A1 filed by The Penn State Research Foundation for a multi-destination procedure planning and guidance system for endoscopic surgery. The application covers IPC classifications G16H 20/40, G16H 50/50, A61B 1/00, A61B 34/00, A61B 34/10, A61B 34/20, A61B 1/267, and A61B 90/00. The patent is designated for all 38 European Patent Convention contracting states including Germany, France, Italy, Spain, and the United Kingdom.

European Patent - Clinical Event Evaluation - Edwards Lifesciences

The European Patent Office published European patent application EP4505472A1 for Edwards Lifesciences Corporation covering systems and methods for clinical event evaluation in health informatics. The patent includes IPC classifications G16H 10/20, G16H 50/70, G06F 40/20, G16H 15/00, and G16H 50/20, with designated states across EU member states and other European countries.

METHOD FOR PATIENT POSITIONING IN A MEDICAL PROCEDURE AND MEDICAL SYSTEM

The European Patent Office granted patent EP4553843A1 to Koninklijke Philips N.V. on April 8, 2026. The patent covers a method and system for patient positioning in medical procedures, utilizing graphics and visualization technologies. The patent is designated across all EU member states and extended European countries.

Wearoptimo Measurement Analysis Patent EP4482372A1

The European Patent Office granted patent EP4482372A1 to Wearoptimo Pty Ltd covering measurement analysis technology. The patent includes claims related to A61B 5/00 (measuring for diagnostic purposes), G16H 50/30 (ICT for treatments or procedures), and G06N 20/00 (machine learning). The patent is designated for all EPC contracting states including DE, FR, GB, IT, NL, and 24 other jurisdictions.

Hydrogels Cultured Meat Production Patent EP4100445A1

The European Patent Office granted Patent EP4100445A1 to Mosa Meat B.V. for hydrogels used in cultured meat production. The invention covers biomaterial compositions (C08B 37/00, C08L 5/04) and methods for culturing animal cells (C12N 5/00, C12N 5/077). The patent is valid in 31 designated contracting states including major markets across the EU, UK, Switzerland, Norway, and Turkey.

Boosting Homology Directed Repair in Plants (EP4172340A1)

The EPO has granted patent EP4172340A1 to KWS SAAT SE & Co. KGaA for methods of boosting homology directed repair in plants. The patent application (C12N 15/82) was published on April 8, 2026, with inventor Yu Mei. This establishes intellectual property rights in designated European states for agricultural biotechnology applications.

Bisdemethoxycurcumin Compositions for Managing Chronic Obstructive Pulmonary Disease (EP4090340A1)

The European Patent Office published patent application EP4090340A1, filed by Sami-Sabinsa Group Limited, covering compositions comprising bisdemethoxycurcumin for managing chronic obstructive pulmonary disease (COPD). The patent names Muhammed Majeed, Kalyanam Nagabhushanam, Sarang Bani, and Anjali Pandey as inventors. The application is classified under A61K 31/12 (ketone-based therapeutic compositions) with designations across 37 European contracting states including all EU member states.

Method for Preparing Polydopamine Nanomotor Using Urease and Use of Same

USPTO granted Patent US12599571B2 to POSTECH Research and Business Development Foundation for a biocompatible polydopamine nanomotor using urease. The nanomotor is designed to infiltrate bladder walls in biological environments and remain inside the bladder for extended periods. The patent includes 10 claims covering the preparation method and therapeutic applications.

Variance Approval to VarsIQ Media

The FDA Center for Devices and Radiological Health (CDRH) has issued a variance approval letter to VarsIQ Media. Variances are exemptions or waivers from specific regulatory requirements under the Federal Food, Drug, and Cosmetic Act. This approval modifies the applicable regulatory requirements for VarsIQ Media, allowing deviation from certain standard CDRH requirements.

Redirect Health Patent Integrates Healthcare Data Using AI

USPTO granted Patent US12591937B1 to Redirect Health, Inc. on March 31, 2026. The patent covers systems for integrating healthcare data from multiple sources using AI networks to generate predictive outputs. The system incorporates multifaceted authorization to access data from various databases and integrate them into a single data warehouse for predictive analysis.

Post-Discharge Monitoring Threshold Mechanism Patent

USPTO granted Patent US12592142B2 to Koninklijke Philips N.V. covering a mechanism for setting time-dependent thresholds for post-discharge monitoring of target subjects. The patent includes 20 claims and was filed on July 19, 2022.

AI Medical Care Coordination Patent, 24 Claims

The USPTO granted patent US12592299B2 to Care Coordination Systems, LLC on March 31, 2026, covering an AI system for coordinating medical care with 24 claims. The patent describes a system including a hub computing device, data collection for patient and provider information, a graphical user interface for real-time gap analysis, and a neural network providing predictive suggestions. Patent grants establish enforceable intellectual property rights.

European Patent for Kava-Derived Therapeutic Compounds and Methods of Use Thereof

EPO granted patent EP3068416A1 to Kuality Herbceutics LLC and 9 named inventors for kava-derived therapeutic compounds and methods of use. The invention is classified under IPC codes A61K 31/12, A61K 31/353, A61K 31/366 (therapeutic compounds) and A61P 35/00 (cancer treatment). The patent is designated in 36 European states including Germany, France, UK, Italy, Spain, Netherlands, Belgium, Austria, and Switzerland.

UPAR Targeting Peptide for Peroperative Optical Imaging of Invasive Cancer

The EPO published patent application EP3733215A1 for Fluoguide A/S, covering a UPAR targeting peptide for peroperative optical imaging of invasive cancer. The patent names Andreas Kjaer and Morten Persson as inventors and includes designations across multiple European member states including DE, FR, GB, IT, ES, NL, and others. This publication grants intellectual property protection for the novel peptide composition and its diagnostic use in cancer surgery.